RGT 8.62% 26.5¢ argent biopharma limited

100m cannabis facility, page-13

  1. 1,003 Posts.
    lightbulb Created with Sketch. 93
    Australia is proving to be difficult for MXC. It's very fortunate that European countries are handing out licences to anyone who say please nicely.

    PK, what's with the low level CBD talk in cosmetics? Don't MXC have the exclusive rights to the highest CBD strain of marijuana in existence? I'm sure I read that somewhere when they were giving the directors millions of shares.
    PK, do you know the strain they are growing outdoor in Slovenia? Is it their exclusive high CBD strain they told the market about? or is it Fedora 17 (commercially available hemp) which was on their growers application and what Slovenia gave them a licence to grow? Things may have changed, I don't know the answers but I think shareholders deserve some consistency and truth.

    Also Peter, do you know what happened to the sales agreement with Natura laboratories? I raised at the time that this was suspicious as Nature Laboratories was set up 6 months before MXC and at the time was a business registered to a house address in the middle of a small village, had a one page website with a mobile phone number as it's only contact detail.
    Is this $60 million agreement still going ahead? or are these things just quickly forgotten about and dismissed?

    Would love your thoughts on this along with an answer as to why you are a major shareholder and why you specifically ramp only two ASX companies, both of which have Brett Mitchell as a director.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.